Bromocriptine/SKF38393 ameliorates islet dysfunction in the diabetic (db/db) mouse.
Dysfunction of pancreatic islets plays a crucial role in the etiology of type II diabetes. Chronic hyperglycaemia or hyperlipidaemia may impair islet function. Previous studies by our laboratory have demonstrated that dopaminergic agonists ameliorated hyperglycaemia and hyperlipidaemia in obese and diabetic rodents. In the present study, we investigated the effect of a treatment with the dopamine D2/D1 receptor agonists (bromocriptine/SKF38393, BC/SKF) on islet dysfunction in db/db mice. Our results show that a 2-week BC/SKF treatment markedly reduced hyperglycaemia and hyperlipidaemia, and significantly improved islet dysfunction demonstrated by an increase of secretagogue-stimulated insulin release from islets of db/db mice to levels observed in islets from lean mice. There was also a fourfold increase of insulin content in the pancreas of BC/SKF-treated db/db mice compared with that in untreated controls. The effect of BC/SKF on islet function cannot be mimicked in pair-fed animals. BC/SKF had no direct stimulatory effect on islet insulin secretion, suggesting BC/SKF treatment improved islet function via an indirect mechanism. This treatment markedly improved the abnormally elevated daily levels of corticosterone, blood glucose and plasma lipids, supporting the view that BC/SKF may affect the neuroendocrine system that in turn regulates peripheral metabolism and thereby improves islet function.
Ergoscience, Charlestown, Massachusetts 02129, USA. yliang@ergo.com
Y
Y
Liang
T L
TL
Jetton
M
M
Lubkin
A H
AH
Meier
A H
AH
Cincotta
D000818:Animals; D001786:Blood Glucose / Q000187:drug effects; D001971:Bromocriptine / Q000494:pharmacology*; D003345:Corticosterone / Q000097:blood; D003924:Diabetes Mellitus, Type 2; D004195:Disease Models, Animal; D018491:Dopamine Agonists / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D007150:Immunohistochemistry; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000187:drug effects* / Q000473:pathology; D008055:Lipids / Q000097:blood; D051379:Mice; D008820:Mice, Obese; D010179:Pancreas / Q000187:drug effects / Q000473:pathology
D001786:Blood Glucose; D018491:Dopamine Agonists; D007328:Insulin; D008055:Lipids; D001971:Bromocriptine; D003345:Corticosterone